SavedAdd your journal

Journals / Retina-Vitreus / 2022 / Cilt: 31 - Sayı: 3

Anti-VEGF Treatment and Results in a Child with Juxtapapillary Choroidal Neovascular Membrane Secondary to Optic Disc Drusen

Enver MİRZA
Günsu Deniz Mirza
Günhal ŞATIRTAV AKDENİZ
Refik OLTULU
Hürkan KERİMOĞLU
Pages
267–270
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After 6 month follow-up, BCVA was 10/10 in the right eye and improved to 63/100 in the left eye.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 16-year-old patient was referred to our clinic with the complaint of blurred vision in the right eye.
📊
Key Findings & Data:The best-corrected visual acuity (BCVA) was 8/10 in the right eye and 10/10 in the left eye.
💡
Conclusion & Impact:After 6 month follow-up, BCVA was 10/10 in the right eye and improved to 63/100 in the left eye.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 16-year-old patient was referred to our clinic with the complaint of blurred vision in the right eye. The best-corrected visual acuity (BCVA) was 8/10 in the right eye and 10/10 in the left eye. Fundus examination revealed bilateral slightly elevated optic disc (OD) with blurred margins. Optical coherence tomography (OCT) imaging showed subretinal fluid in the right eye at presentation and in the left eye during the follow-up. The patient was diagnosed with bilateral choroidal neovascular membrane (CNVM) secondary to optic disc drusen (ODD) and treated with intravitreal ranibizumab injections. In control visit on month 1, vision improved and the subretinal fluid was decreased in the right eye. BCVA decreased in the left eye and presented subretinal fluid at the nasal side of the macula. Therefore, bilateral ranibizumab injection was performed by 2-week interval, primarily on the left eye. After 6 month follow-up, BCVA was 10/10 in the right eye and improved to 63/100 in the left eye.

🔖

Cite This Article

MİRZA, E., Mirza, G. D., AKDENİZ, G. Ş., OLTULU, R., KERİMOĞLU, H. (2022). Anti-VEGF Treatment and Results in a Child with Juxtapapillary Choroidal Neovascular Membrane Secondary to Optic Disc Drusen. Retina-Vitreus, Cilt: 31 - Sayı: 3, 267–270. https://ajindex.com/articles/589021

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Erkkila H. Clinical appearance of optic disc drusen in childhood. Albrecht Von Graefes Arch Klin Exp Ophthalmol 1975;193:1- 18
  2. Friedman AH, Henkind P, Gartner S. Drusen of the optic disc. A histopathological study. Trans Ophthalmol Soc U K. 1975;95:4- 9 3. Auw-Haedrich C, Staubach F, Witschel H. Optic disk drusen. Surv Ophthalmol. 2002;47:515-32 4. Mateo C, Moreno JG, Lechuga M, ve ark. Surgical removal of peripapillary choroidal neovascularization associated with optic nerve drusen. Retina 2004; 24: 739–45
  3. Kramer M, Axer-Siegel R, Jaouni T, ve ark. Bevacizumab for choroidal neovascularization related to inflammatorydiseases. Retina 2010;30:938-44
  4. Cakir M, Cekic ̧ O, Yilmaz OF. Combined intravitreal bevacizumab and triamcinolone injection in a child with Coats disease. J AAPOS 2008;12:309-11
  5. Cakir M, Cekic ̧ O, Yilmaz OF. Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease. J AAPOS 2009;13:94-6
  6. Delyfer MN, Rougier MB, Fourmaux E, ve ark. Laser photocoagulation for choroidal neovascular membrane associated with optic disc drusen. Acta Ophthalmol Scand 2004;82:236-8
  7. Silva R, Torrent T, Loureiro R,ve ark. Bilateral CNV associated with optic nerve drusen treated with photodynamic therapy with verteporfin. Eur J Ophthalmol 2004;14:434-7
  8. Alkin Z, Ozkaya A, Yilmaz I, ve ark. A single injection of intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to optic nerve head drusen in a child. BMJ Case Reports 2014: 11. Baillif S, Nguyen E, Colleville-El Hayek A, ve ark. And one long-term follow-up of a child treated with ranibizumab: long term follow-up after a single intravitreal ranibizumab injection for choroidal neovascularisation secondary to optic nerve head drusen in a 5-year-old child. Graefes Arch Clin Exp Ophthalmol 2013;251:1657–9
  9. Delas B, Almudi L, Carreras A, ve ark. Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy. Clin Ophthalmol 2012;6:225–30
  10. Gregory-Evans K, Rai P, Patterson J. Successful treatment of subretinal neovascularization with intravitreal ranibizumab in a child with optic nerve head drusen. J Pediatr Ophthalmol Strabismus 2009
  11. Knape RM, Zavaleta EM, Clark CL III, ve ark. Intravitreal bevacizumab treatment of bilateral peripapillary choroidal neovascularization from optic nerve head drusen. J AAPOS 2011;15:87–90.